MedDataX Logo

Treatment of Panic Disorder Via Internet With a Wireless Temperature Biofeedback Ring

NCT ID: NCT00825136

Last Updated: 2012-08-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-07-31

Study Completion Date

2009-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Internet plays a more and more important role in many applications of healthcare. Many researches on the integrations of internet and mental health care have been proposed in recent years. This project aims at the development of an online treatment system which combines the biofeedback therapy and the web technologies to treat the patients suffering from panic disorder with partial response to medications. This project also evaluates the efficacy of a new- designed wireless temperature biofeedback ring.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The participants should be chronic panic patients. They login an web-based server and practice muscle relaxation on-line every day. There will be two two parallel groups: one group practicing muscle relaxation only and the other practicing muscle relaxation with finger surface temperature monitor through a wireless biofeedback ring.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Panic Disorder

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Panic Disorder Temperature Biofeedback Internet

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

relaxation

The patients of this arm practice on-line muscle relaxation for 8 weeks.

Group Type ACTIVE_COMPARATOR

relaxation

Intervention Type BEHAVIORAL

Participants were asked to log in the system to keep the muscle relaxation program every day and complete some self-rating scales on browser every week.

relaxation & biofeedback

The patients of this arm practice on-line muscle relaxation plus finger temperature biofeedback for 8 weeks.

Group Type EXPERIMENTAL

relaxation

Intervention Type BEHAVIORAL

Participants were asked to log in the system to keep the muscle relaxation program every day and complete some self-rating scales on browser every week.

biofeedback (finger temperature biofeedback)

Intervention Type BEHAVIORAL

Participants were asked to log in the system to keep the muscle relaxation program plus finger temperature biofeedback every day and complete some self-rating scales on browser every week.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

relaxation

Participants were asked to log in the system to keep the muscle relaxation program every day and complete some self-rating scales on browser every week.

Intervention Type BEHAVIORAL

biofeedback (finger temperature biofeedback)

Participants were asked to log in the system to keep the muscle relaxation program plus finger temperature biofeedback every day and complete some self-rating scales on browser every week.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. The participant must fulfill DSM-IV criteria for panic disorder.
2. The participant must be between 18 and 60 years of age.
3. The participant must have panic disorder as the primary problem.
4. If the participant is taking prescribed drugs for panic disorder, a) the dosage have to be constant for 2 months before starting treatment, and b) the participant have to agree to keep the dosage constant for 1 month after starting treatment.
5. If the participant was already in therapy, the contact must have lasted at least 6 months and not be based on cognitive behavior therapy.
6. All participants have access to a computer with an Internet connection.

Exclusion Criteria

1. The participant suffers from any other psychiatric disorder in immediate need of treatment.
2. The participant fulfills DSM-IV criteria for major depression.
3. The participant has epilepsy, kidney problems, strokes, organic brain syndrome, emphysema, heart disorders, or chronic hypertension. 4. The participant has alcoholism.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chimei Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Fong-Lin Jang

Department of Psychiatry

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Fong-Lin Jang, M.D.

Role: STUDY_DIRECTOR

Chimei Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Psychiatry Department, Chimei Medical Center

Tainan City, , Taiwan

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Taiwan

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB 09707-001

Identifier Type: -

Identifier Source: org_study_id